Table 1.
Relative Risk | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AI | Amoxicillin | Co-Amoxiclav | III-Gen. Cephalosporins | II-Gen. Cephalosporins | Macrolides | Lincosamides | Fluoroquinolones | J01XX | Thiamphenicol | Other Aminoglycosides | Other | |
Time in year | 0.96 (0.96–0.97) | 1.02 (1.01–1.02) | 1.01 (1.01–1.02) | 1 (1–1) | 0.9 (0.89–0.9) | 0.99 (0.99–0.99) | 1.03 (0.99–1.07) | 0.91 (0.85–0.96) | 0.98 (0.96–1) | 1.02 (1.01–1.03) | 0.95 (0.94–0.96) | 0.83 (0.8–0.86) |
Patients’ age in years | 0.87 (0.87–0.87) | 0.94 (0.94–0.94) | 1.01 (1.01–1.01) | 1.01 (1.01–1.01) | 0.93 (0.93–0.94) | 1.04 (1.04–1.04) | 1.2 (1.18–1.23) | 1.13 (1.09–1.17) | 1.17 (1.16–1.18) | 0.94 (0.93–0.94) | 1.14 (1.13–1.15) | 1.07 (1.05–1.09) |
Male sex | 1.05 (1.04–1.06) | 0.99 (0.97–1) | 1.04 (1.03–1.05) | 0.97 (0.96–0.99) | 0.91 (0.89–0.94) | 1.03 (1.02–1.04) | 1.32 (1.13–1.54) | 1.38 (1.08–1.76) | 1.02 (0.94–1.1) | 0.55 (0.52–0.57) | 1 (0.94–1.05) | 1.11 (0.97–1.26) |
Geographical location | ||||||||||||
North | ref | ref | ref | ref | ref | ref | ref | ref | ref | ref | ref | ref |
Centre | 1.72 (1.71–1.74) | 0.35 (0.35–0.36) | 1.8 (1.78–1.83) | 1.37 (1.35–1.4) | 1.59 (1.53–1.65) | 0.92 (0.9–0.94) | 0.38 (0.28–0.5) | 4.4 (3.01–6.41) | 0.51 (0.46–0.56) | 1.5 (1.4–1.61) | 0.71 (0.66–0.77) | 0.84 (0.72–0.99) |
South and islands | 1.75 (1.74–1.76) | 0.28 (0.28–0.29) | 1.33 (1.31–1.34) | 1.96 (1.93–1.99) | 1.88 (1.83–1.94) | 1.33 (1.32–1.35) | 0.88 (0.75–1.03) | 3.22 (2.27–4.57) | 0.27 (0.25–0.3) | 1.98 (1.87–2.09) | 0.81 (0.76–0.86) | 0.23 (0.19–0.28) |